Target intelligence / Profile preview

Respiratory tract epithelium

Molecular classification
Other (epithelial tissue type)
01

Overview

The respiratory tract epithelium is a tissue type lining the majority of the airway surfaces, composed predominantly of ciliated pseudostratified columnar epithelial cells, goblet cells, basal cells, and in more distal bronchioles, club cells and alveolar epithelial cells. Its primary roles are to humidify air, trap and clear pathogens and particulates through mucociliary action, and function as a dynamically regulated barrier involved in immune responses. The epithelium is pivotal in maintaining respiratory homeostasis and is highly adaptive and regenerative after injury. Dysfunction of the respiratory epithelium is central to the pathogenesis of various airway diseases, including asthma, COPD, cystic fibrosis, and respiratory infections; thus, it is a non-specific tissue "target" for inhaled or topical therapies, but not a canonical drug target in the molecular sense.

Other names
Respiratory epitheliumAirway epitheliumRespiratory mucosa
02

Mechanism of action

For glucocorticoids and anti-inflammatory drugs, the primary actions are reduction of inflammation, modulation of epithelial cytokine secretion, and restoration of barrier function

03

Biological functions

Physical barrier to pathogensMucociliary clearanceImmunological signalingSecretion of mucus and antimicrobial factorsGas exchange facilitation (in alveolar regions via specialized epithelial cells)Tissue repair and regeneration
04

Disease associations

Infection (first-line defense, influenza, common cold, COVID-19)Inflammation (asthma, chronic obstructive pulmonary disease, cystic fibrosis)Other (barrier impairment in hyperglycemia, injury, allergies)
05

Safety considerations

Impaired epithelial repair increases infection riskExcess mucus production can obstruct airways in diseases like asthma, COPD, cystic fibrosisCompromised barrier increases allergen penetration and inflammation
06

Interacting drugs

Glucocorticoids (act on airway epithelium in asthma and inflammation)

1 more in the full profile.

07

Biomarkers

Epithelial cell injury/repair markers (e.g., cytokeratins, Trp-63 for basal cells)Goblet cell hyperplasia (in asthma, COPD)Mucin levels (MUC5AC, MUC5B, associated with disease states)

Beyond the preview

Go deeper on Respiratory tract epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory tract epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call